In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
|Videos|January 11, 2019
Challenges in Oncology Pharmacy
Author(s)Howard Cohen RPh, MS, FASHP
Howard Cohen, RPh, MS, FASHP, director of oncology pharmacy services, Smilow Cancer Center, Yale New Haven Health, discusses the challenges of cancer treatment from a pharmacy perspective.
Advertisement
Regulatory demands, scarcity of trained oncology pharmacists, and the increasingly high cost of drugs are some barriers to optimal pharmaceutical support of patients, says Howard Cohen, RPh, MS, FASHP. Cohen is director of oncology pharmacy services, Smilow Cancer Center, Yale New Haven Health. In this video, captured during the 2018 National Community Oncology Dispensing Association (NCODA) Fall Summit, he discusses the challenges of cancer treatment from a pharmacy perspective.
Advertisement
Related to this article
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
2
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
3
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
4
Multidisciplinary Support for Patients with Metastatic Triple-Negative Breast Cancer
5